Cargando…

Pre-analytic factors and initial biomarker levels in community- acquired pneumonia patients

Detalles Bibliográficos
Autores principales:	Kutz, A, Grolimund, E, Mueller, B, Schuetz, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068382/ http://dx.doi.org/10.1186/cc13411

Ejemplares similares

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients
por: Kutz, Alexander, et al.
Publicado: (2014)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Procalcitonin-guided antibiotic therapy in patients with congestive heart failure and suspicion of lower respiratory tract infection: results from a randomized trial
por: Schuetz, P, et al.
Publicado: (2013)

Long-term outcome in COPD patients with pneumonic and nonpneumonic exacerbation: a 6-year prospective follow-up study
por: Grolimund, EG, et al.
Publicado: (2014)

Prognostic value of procalcitonin in respiratory tract infections across clinical settings
por: Kutz, A, et al.
Publicado: (2015)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial
por: Blum, CA, et al.
Publicado: (2015)

Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012)

Mathematical modeling of community-acquired pneumonia patients
por: Sarkar, J, et al.
Publicado: (2009)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Unraveling the link between malnutrition and adverse clinical outcomes: association of acute and chronic malnutrition measures with blood biomarkers from different pathophysiological systems
por: Felder, S, et al.
Publicado: (2015)

Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)

Host genetic variants associated with community-acquired pneumonia
por: Salnikova, LE, et al.
Publicado: (2013)

Outcome of severe community-acquired pneumonia: the impact of comorbidities
por: Pereira, JM, et al.
Publicado: (2013)

Racial disparities in quality of care in community-acquired pneumonia
por: Mayr, FB, et al.
Publicado: (2008)

Simple and fast prediction of Legionella sp. in community-acquired pneumonia: validation of a prediction rule
por: Haubitz, S, et al.
Publicado: (2013)

Is inappropriate secretion of anti-diuretic hormone (SIADH) the cause of hyponatremia in Legionella pneumonia?
por: Schuetz, P, et al.
Publicado: (2012)

Severity of illness scoring systems in community-acquired Legionella pneumonia
por: Simonsen, Ø, et al.
Publicado: (2010)

Validation of predictive rules for ICU patients with community-acquired pneumonia
por: Rudnov, V, et al.
Publicado: (2008)

Early risk stratification in patients with oncological and hematological malignancies in the emergency department
por: Rast, A, et al.
Publicado: (2014)

Clinical scores and blood biomarkers for Prediction of bacteremia in emergency department patients: Bacteremia Assessment in Clinical Triage (BACT) study
por: Laukemann, S, et al.
Publicado: (2015)

A new severity score for community-acquired pneumonia: PARB score
por: Uchiyama, N, et al.
Publicado: (2010)

Criteria of the systemic inflammatory response syndrome in patients with community-acquired pneumonia
por: Ustyantseva, I, et al.
Publicado: (2006)

Coagulation in hospitalized community-acquired pneumonia: disturbances in even the least ill
por: Reade, MC, et al.
Publicado: (2008)

Association of C-Reactive Protein and Outcome in Patients With Community-Acquired Pneumonia
por: Park, JK, et al.
Publicado: (2015)

Validation of B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients: a prospective multinational trial
por: Kutz, A, et al.
Publicado: (2015)

Analysis of the mortality rate in patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

Severe pneumonia in critically ill cancer patients: clinical outcomes and a comparison between healthcare-associated pneumonia and community-acquired pneumonia
por: Rabello, Ligia SCF, et al.
Publicado: (2013)

Use of statins in community-acquired pneumonia in intensive care settings: is there a survival advantage?
por: Khanna, A, et al.
Publicado: (2011)

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia
por: Suberviola, B, et al.
Publicado: (2011)

Beneficial effects of antiplatelet drugs in patients with community-acquired pneumonia and in endotoxin shock in mice
por: Winning, J, et al.
Publicado: (2007)

Effects of systemic steroid in patients with severe community-acquired pneumonia requiring mechanical ventilation
por: Chon, G, et al.
Publicado: (2009)

Defining severe community-acquired pneumonia: a significant barrier to improving patient outcomes
por: Balp, MM, et al.
Publicado: (2009)

Assessment of specific risk scores for patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

The Manchester Triage System in optimizing triage in adult general medical emergency patients: the Triage Project
por: Steiner, D, et al.
Publicado: (2014)

PReS-FINAL-2346: Hypomorphic RAG deficiencies: phenotypic variability and usefulness of TREC/KREC as diagnostic biomarkers
por: Schuetz, C, et al.
Publicado: (2013)

Association of prior statin therapy with cytokine profiles and outcomes in patients hospitalized with community acquired pneumonia
por: Milbrandt, E, et al.
Publicado: (2005)

Age-related differences of outcomes in patients hospitalized with community-acquired pneumonia are not explained by differences in immune response
por: Kale, S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r9bu9umll7rrghi4l11g74jbs3